Detalhe da pesquisa
1.
Influence of chronic obstructive pulmonary disease on long-term hospitalization and mortality in patients with heart failure with reduced ejection fraction.
BMC Pulm Med
; 23(1): 67, 2023 Feb 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36805703
2.
Afatinib treatment in a large real-world cohort of nonsmall cell lung cancer patients with common and uncommon epidermal growth factor receptor mutation.
Int J Cancer
; 150(4): 626-635, 2022 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34558665
3.
Factors associated with prolonged progression-free survival of patients treated with first-line afatinib for advanced epidermal growth factor receptor-mutated non-small cell lung cancer.
Thorac Cancer
; 15(7): 529-537, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38279515
4.
Differential prognostic value of tumor and plasma T790M mutations in EGFR TKI-treated advanced NSCLC.
Ther Adv Med Oncol
; 16: 17588359231222604, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38249338
5.
Afatinib in Untreated Stage IIIB/IV Lung Adenocarcinoma with Major Uncommon Epidermal Growth Factor Receptor (EGFR) Mutations (G719X/L861Q/S768I): A Multicenter Observational Study in Taiwan.
Target Oncol
; 18(2): 195-207, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36805452
6.
Brain metastasis, EGFR mutation subtype and generation of EGFR-TKI jointly influence the treatment outcome of patient with EGFR-mutant NSCLC.
Sci Rep
; 13(1): 20323, 2023 11 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37989860
7.
Sequential treatment in advanced epidermal growth factor receptor-mutated lung adenocarcinoma patients receiving first-line bevacizumab combined with 1st/2nd-generation EGFR-tyrosine kinase inhibitors.
Front Oncol
; 13: 1249106, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37854677
8.
Feasibility and Safety of Transbronchial Lung Cryobiopsy for Diagnosis of Acute Respiratory Failure with Mechanical Ventilation in Intensive Care Unit.
Diagnostics (Basel)
; 12(12)2022 Nov 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36552923
9.
Comparison of afatinib and erlotinib combined with bevacizumab in untreated stage IIIB/IV epidermal growth factor receptor-mutated lung adenocarcinoma patients: a multicenter clinical analysis study.
Ther Adv Med Oncol
; 14: 17588359221113278, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35898964
10.
Afatinib Treatment Alone or with Bevacizumab in a Real-World Cohort of Non-Small Cell Lung Cancer Patients with Epidermal Growth Factor Receptor Mutation.
Cancers (Basel)
; 14(2)2022 Jan 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35053480
11.
The different overall survival between single-agent EGFR-TKI treatment and with bevacizumab in non-small cell lung cancer patients with brain metastasis.
Sci Rep
; 12(1): 4398, 2022 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35292755
12.
Durvalumab as Consolidation Therapy in Post-Concurrent Chemoradiation (CCRT) in Unresectable Stage III Non-Small Cell Lung Cancer Patients: A Multicenter Observational Study.
Vaccines (Basel)
; 9(10)2021 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34696229
13.
Predicting mortality in non-cystic fibrosis bronchiectasis patients using distance-saturation product.
Ann Med
; 53(1): 2034-2040, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34761709
14.
First- or second-generation epidermal growth factor receptor tyrosine kinase inhibitors in a large, real-world cohort of patients with non-small cell lung cancer.
Ther Adv Med Oncol
; 13: 17588359211035710, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34377157